Virtual Reality Improves Symptoms of Functional Dyspepsia: Results of a Randomized, Double-Blind, Sham-Controlled, Pilot Study.
| Autor: | Cangemi DJ; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA., Montenegro M; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA., Spiegel BMR; Division of Health Sciences Research, Department of Medicine, Cedars-Sinai Health System, Los Angeles, California, USA., Lacy ABE; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The American journal of gastroenterology [Am J Gastroenterol] 2024 Jan 01; Vol. 119 (1), pp. 210-213. Date of Electronic Publication: 2023 Sep 01. |
| DOI: | 10.14309/ajg.0000000000002492 |
| Abstrakt: | Introduction: We investigated the efficacy and safety of virtual reality (VR) for functional dyspepsia. Methods: Patients were randomized 2:1 between active vs sham VR. Symptoms were assessed using the Patient Assessment of Gastrointestinal Disorders-Symptom Severity Index (PAGI-SYM) over 2-week. Results: Patients in the active VR group had greater numerical improvement in PAGI-SYM scores (mean difference -0.7; P < 0.001) compared with sham VR (mean difference -0.4; P = 0.032). Active VR led to significant improvements for all PAGI-SYM subscales, except lower abdominal pain, whereas sham only improved heartburn/regurgitation and nausea/vomiting. Half of the total patients reported nonserious adverse effects, although only 1 patient withdrew from the study because of adverse effects. Discussion: VR is safe and results in significant symptom improvement in functional dyspepsia. Larger trials are warranted. (Copyright © 2023 by The American College of Gastroenterology.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|